These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36831011)

  • 21. IDH2 deficiency promotes mitochondrial dysfunction and cardiac hypertrophy in mice.
    Ku HJ; Ahn Y; Lee JH; Park KM; Park JW
    Free Radic Biol Med; 2015 Mar; 80():84-92. PubMed ID: 25557279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
    Hsin IL; Wang SC; Li JR; Ciou TC; Wu CH; Wu HM; Ko JL
    Phytomedicine; 2016 Dec; 23(13):1566-1573. PubMed ID: 27823620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
    Wangpaichitr M; Wu C; Li YY; Nguyen DJM; Kandemir H; Shah S; Chen S; Feun LG; Prince JS; Kuo MT; Savaraj N
    Oncotarget; 2017 Jul; 8(30):49275-49292. PubMed ID: 28525376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IDH2 deficiency impairs cutaneous wound healing via ROS-dependent apoptosis.
    Kim SH; Park JW
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165523. PubMed ID: 31376482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin resistance in human cervical, ovarian and lung cancer cells.
    Chen J; Solomides C; Parekh H; Simpkins F; Simpkins H
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1217-27. PubMed ID: 25894720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism.
    Ye S; Xu P; Huang M; Chen X; Zeng S; Wang Q; Chen J; Li K; Gao W; Liu R; Liu J; Shao Y; Zhang H; Xu Y; Zhang Q; Zhong Z; Wei Z; Wang J; Hao B; Huang W; Liu Q
    Cell Death Dis; 2020 May; 11(5):312. PubMed ID: 32366855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agrimoniin sensitizes pancreatic cancer to apoptosis through ROS-mediated energy metabolism dysfunction.
    Zhu X; Zhang Y; Wang Y; Zhang H; Wang X; Tang H; Huang H; Zhou Z; Chen B; Sun L
    Phytomedicine; 2022 Feb; 96():153807. PubMed ID: 34785107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.
    Kim EH; Jang H; Roh JL
    Mol Cancer Ther; 2016 Nov; 15(11):2620-2629. PubMed ID: 27550943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition.
    Cruz-Bermúdez A; Laza-Briviesca R; Vicente-Blanco RJ; García-Grande A; Coronado MJ; Laine-Menéndez S; Palacios-Zambrano S; Moreno-Villa MR; Ruiz-Valdepeñas AM; Lendinez C; Romero A; Franco F; Calvo V; Alfaro C; Acosta PM; Salas C; Garcia JM; Provencio M
    Free Radic Biol Med; 2019 May; 135():167-181. PubMed ID: 30880247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells.
    Wang Q; Zheng XL; Yang L; Shi F; Gao LB; Zhong YJ; Sun H; He F; Lin Y; Wang X
    J Exp Clin Cancer Res; 2010 Dec; 29(1):159. PubMed ID: 21143894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NBM-T-BMX-OS01, an Osthole Derivative, Sensitizes Human Lung Cancer A549 Cells to Cisplatin through AMPK-Dependent Inhibition of ERK and Akt Pathway.
    Chen TJ; Zhou YF; Ning JJ; Yang T; Ren H; Li Y; Zhang S; Chen MW
    Cell Physiol Biochem; 2015; 36(3):893-906. PubMed ID: 26065336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of TRAP1 promotes cisplatin-induced apoptosis by promoting the ROS-dependent mitochondrial dysfunction in lung cancer cells.
    Zhang X; Dong Y; Gao M; Hao M; Ren H; Guo L; Guo H
    Mol Cell Biochem; 2021 Feb; 476(2):1075-1082. PubMed ID: 33196942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IDH2 deficiency accelerates skin pigmentation in mice via enhancing melanogenesis.
    Park JH; Ku HJ; Lee JH; Park JW
    Redox Biol; 2018 Jul; 17():16-24. PubMed ID: 29660504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in
    Valvo V; Iesato A; Kavanagh TR; Priolo C; Zsengeller Z; Pontecorvi A; Stillman IE; Burke SD; Liu X; Nucera C
    Thyroid; 2021 Sep; 31(9):1335-1358. PubMed ID: 33107403
    [No Abstract]   [Full Text] [Related]  

  • 35. IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies.
    Bergaggio E; Riganti C; Garaffo G; Vitale N; Mereu E; Bandini C; Pellegrino E; Pullano V; Omedè P; Todoerti K; Cascione L; Audrito V; Riccio A; Rossi A; Bertoni F; Deaglio S; Neri A; Palumbo A; Piva R
    Blood; 2019 Jan; 133(2):156-167. PubMed ID: 30455381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway.
    Wei X; Shi J; Lin Q; Ma X; Pang Y; Mao H; Li R; Lu W; Wang Y; Liu P
    Front Oncol; 2021; 11():642229. PubMed ID: 33816292
    [No Abstract]   [Full Text] [Related]  

  • 37. SUMOylation enhances the activity of IDH2 under oxidative stress.
    Yu Y; Chen Y; Liu K; Cheng J; Tu J
    Biochem Biophys Res Commun; 2020 Nov; 532(4):591-597. PubMed ID: 32900482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetrathiomolybdate as an old drug in a new use: As a chemotherapeutic sensitizer for non-small cell lung cancer.
    Li Y; Fang M; Xu Z; Li X
    J Inorg Biochem; 2022 Aug; 233():111865. PubMed ID: 35623139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics.
    Wang L; Chen X; Du Z; Li G; Chen M; Chen X; Liang G; Chen T
    J Exp Clin Cancer Res; 2017 Mar; 36(1):47. PubMed ID: 28359291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation.
    Kaminskyy VO; Piskunova T; Zborovskaya IB; Tchevkina EM; Zhivotovsky B
    Autophagy; 2012 Jul; 8(7):1032-44. PubMed ID: 22562073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.